{"id":15292,"date":"2023-08-10T22:25:00","date_gmt":"2023-08-10T14:25:00","guid":{"rendered":"https:\/\/flcube.com\/?p=15292"},"modified":"2024-11-27T22:27:21","modified_gmt":"2024-11-27T14:27:21","slug":"neurophth-biotechnology-secures-rmb700-million-in-series-c-financing-for-gene-therapy-development","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=15292","title":{"rendered":"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development"},"content":{"rendered":"\n<p>China-based gene therapy specialist Neurophth Biotechnology Ltd has reportedly secured close to RMB700 million in a Series C+ financing round. The round was led by Changjiang Zhaoyin Industrial Fund, Optics Valley Financial Holing, Wuhan Hi-Tech, and Optics Valley Industrial Investment, all state-owned entities, along with Guangzhou Finance Holdings. This financing includes contributions from SDIC Investment, Silicon Paradise Equity Investment, and Yangtze Investment. The funds will be utilized to accelerate clinical trials, enhance R&amp;D capabilities, and expand the company&#8217;s product pipeline.<\/p>\n\n\n\n<p><strong>NR082: A Milestone in Gene Therapy<\/strong><br>Neurophth\u2019s flagship product, NR082 (rAAV2-ND4, NFS-01), a recombinant adeno-associated virus serotype 2 (rAAV2), has become the first of its kind to complete Phase III study enrollment in China this year. Additionally, it has finalized the first patient enrollment of a Phase I\/II study in the US. This achievement marks a significant step forward in the development of gene therapy treatments for retinal diseases.<\/p>\n\n\n\n<p><strong>NFS-02: A Global First in ND1-LHON Gene Therapy<\/strong><br>The company&#8217;s second gene therapy, NFS-02 (rAAV2-ND1), which targets ND1 mutation-induced Leber hereditary optic neuropathy (ND1-LHON), is currently the world\u2019s only gene therapy for this condition. It has received tacit approval for clinical trials in both China and the US, highlighting Neurophth\u2019s leading position in the gene therapy space.<a href=\"https:\/\/flcube.com\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based gene therapy specialist Neurophth Biotechnology Ltd has reportedly secured close to RMB700 million in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[66,1520],"class_list":["post-15292","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-gene-therapy","tag-neurophth-biotechnology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based gene therapy specialist Neurophth Biotechnology Ltd has reportedly secured close to RMB700 million in a Series C+ financing round. The round was led by Changjiang Zhaoyin Industrial Fund, Optics Valley Financial Holing, Wuhan Hi-Tech, and Optics Valley Industrial Investment, all state-owned entities, along with Guangzhou Finance Holdings. This financing includes contributions from SDIC Investment, Silicon Paradise Equity Investment, and Yangtze Investment. The funds will be utilized to accelerate clinical trials, enhance R&amp;D capabilities, and expand the company&#039;s product pipeline.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=15292\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=15292\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-10T14:25:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-27T14:27:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15292#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15292\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development\",\"datePublished\":\"2023-08-10T14:25:00+00:00\",\"dateModified\":\"2024-11-27T14:27:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15292\"},\"wordCount\":234,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Gene therapy\",\"Neurophth Biotechnology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=15292#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15292\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=15292\",\"name\":\"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-08-10T14:25:00+00:00\",\"dateModified\":\"2024-11-27T14:27:21+00:00\",\"description\":\"China-based gene therapy specialist Neurophth Biotechnology Ltd has reportedly secured close to RMB700 million in a Series C+ financing round. The round was led by Changjiang Zhaoyin Industrial Fund, Optics Valley Financial Holing, Wuhan Hi-Tech, and Optics Valley Industrial Investment, all state-owned entities, along with Guangzhou Finance Holdings. This financing includes contributions from SDIC Investment, Silicon Paradise Equity Investment, and Yangtze Investment. The funds will be utilized to accelerate clinical trials, enhance R&D capabilities, and expand the company's product pipeline.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15292#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=15292\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=15292#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development - Insight, China&#039;s Pharmaceutical Industry","description":"China-based gene therapy specialist Neurophth Biotechnology Ltd has reportedly secured close to RMB700 million in a Series C+ financing round. The round was led by Changjiang Zhaoyin Industrial Fund, Optics Valley Financial Holing, Wuhan Hi-Tech, and Optics Valley Industrial Investment, all state-owned entities, along with Guangzhou Finance Holdings. This financing includes contributions from SDIC Investment, Silicon Paradise Equity Investment, and Yangtze Investment. The funds will be utilized to accelerate clinical trials, enhance R&D capabilities, and expand the company's product pipeline.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=15292","og_locale":"en_US","og_type":"article","og_title":"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=15292","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-08-10T14:25:00+00:00","article_modified_time":"2024-11-27T14:27:21+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=15292#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=15292"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development","datePublished":"2023-08-10T14:25:00+00:00","dateModified":"2024-11-27T14:27:21+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=15292"},"wordCount":234,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Gene therapy","Neurophth Biotechnology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=15292#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=15292","url":"https:\/\/flcube.com\/?p=15292","name":"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-08-10T14:25:00+00:00","dateModified":"2024-11-27T14:27:21+00:00","description":"China-based gene therapy specialist Neurophth Biotechnology Ltd has reportedly secured close to RMB700 million in a Series C+ financing round. The round was led by Changjiang Zhaoyin Industrial Fund, Optics Valley Financial Holing, Wuhan Hi-Tech, and Optics Valley Industrial Investment, all state-owned entities, along with Guangzhou Finance Holdings. This financing includes contributions from SDIC Investment, Silicon Paradise Equity Investment, and Yangtze Investment. The funds will be utilized to accelerate clinical trials, enhance R&D capabilities, and expand the company's product pipeline.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=15292#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=15292"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=15292#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/15292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15292"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/15292\/revisions"}],"predecessor-version":[{"id":15293,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/15292\/revisions\/15293"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}